| Genetic control of programmed cell death (apoptosis) in Drosophila D Xu, SE Woodfield, TV Lee, Y Fan, C Antonio, A Bergmann Fly 3 (1), 78-90, 2009 | 141 | 2009 |
| Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression SE Woodfield, L Zhang, KA Scorsone, Y Liu, PE Zage BMC cancer 16, 1-10, 2016 | 64 | 2016 |
| The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model J Lu, S Guan, Y Zhao, Y Yu, SE Woodfield, H Zhang, KL Yang, ... Cancer letters 400, 61-68, 2017 | 44 | 2017 |
| Common and Distinct Genetic Properties of ESCRT-II Components in Drosophila HM Herz, SE Woodfield, Z Chen, C Bolduc, A Bergmann PLoS One 4 (1), e4165, 2009 | 44 | 2009 |
| Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition L Zhang, K Scorsone, SE Woodfield, PE Zage Cancer chemotherapy and pharmacology 76, 977-987, 2015 | 32 | 2015 |
| Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling S Bieerkehazhi, Z Chen, Y Zhao, Y Yu, H Zhang, SA Vasudevan, ... Oncotarget 8 (1), 1469, 2017 | 30 | 2017 |
| MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma SE Woodfield, Y Shi, RH Patel, Z Chen, AP Shah, RK Srivastava, ... Scientific reports 11 (1), 2967, 2021 | 29 | 2021 |
| A novel cell line based orthotopic xenograft mouse model that recapitulates human hepatoblastoma SE Woodfield, Y Shi, RH Patel, J Jin, A Major, SF Sarabia, Z Starosolski, ... Scientific reports 7 (1), 17751, 2017 | 28 | 2017 |
| Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment H Li, Z Chen, T Hu, L Wang, Y Yu, Y Zhao, W Sun, S Guan, JC Pang, ... Scientific reports 6 (1), 34397, 2016 | 27 | 2016 |
| The novel kinase inhibitor EMD1214063 is effective against neuroblastoma K Scorsone, L Zhang, SE Woodfield, J Hicks, PE Zage Investigational new drugs 32, 815-824, 2014 | 26 | 2014 |
| De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to neoplastic tumorigenesis SE Woodfield, HK Graves, JA Hernandez, A Bergmann PLoS One 8 (2), e56021, 2013 | 26 | 2013 |
| Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma X Mao, Z Chen, Y Zhao, Y Yu, S Guan, SE Woodfield, SA Vasudevan, ... Oncotarget 8 (1), 1555, 2017 | 25 | 2017 |
| Notch signaling activates Yorkie non-cell autonomously in Drosophila HK Graves, SE Woodfield, CC Yang, G Halder, A Bergmann PloS one 7 (6), e37615, 2012 | 25 | 2012 |
| Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults P Sumazin, TL Peters, SF Sarabia, HR Kim, M Urbicain, EF Hollingsworth, ... Journal of Hepatology 77 (4), 1026-1037, 2022 | 23 | 2022 |
| The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma SB Whittle, K Patel, L Zhang, SE Woodfield, M Du, V Smith, PE Zage Investigational new drugs 34, 685-692, 2016 | 22 | 2016 |
| TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis S Guan, J Lu, Y Zhao, SE Woodfield, H Zhang, X Xu, Y Yu, J Zhao, ... Oncotarget 8 (20), 33666, 2017 | 21 | 2017 |
| Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling H Li, Y Yu, Y Zhao, D Wu, X Yu, J Lu, Z Chen, H Zhang, Y Hu, Y Zhai, J Su, ... Cancer Letters 457, 129-141, 2019 | 20 | 2019 |
| Nifurtimox is effective against neural tumor cells and is synergistic with buthionine sulfoximine M Du, L Zhang, KA Scorsone, SE Woodfield, PE Zage Scientific reports 6 (1), 27458, 2016 | 19 | 2016 |
| Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo Z Chen, Y Zhao, Y Yu, JC Pang, SE Woodfield, L Tao, S Guan, H Zhang, ... Oncotarget 8 (61), 104090, 2017 | 18 | 2017 |
| Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation J Jin, J Jin, SE Woodfield, RH Patel, NG Jin, Y Shi, B Liu, W Sun, X Chen, ... Oncology reports 41 (1), 143-153, 2019 | 17 | 2019 |
